Mancini Marianna Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$29.34M

Insider Activity of Mancini Marianna

According to the SEC Form 4 filings, Mancini Marianna, being in a position of

  1. Chief Operating Officer at Viking Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 75878 shares for $2.51M,
    over all time since 2023-03-28, has bought 0 shares, and sold 690300 shares for $32.19M.

Biography of Mancini Marianna

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,511,0412100

Comparison of Insiders on Amount of Buys and Sells

2026-07-29SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
18,217
0.0157%
$33.47$609,636-3.84%
2026-01-05SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
57,661
0.0523%
$32.98$1.9M+0.78%
2025-10-28SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
6,185
0.0057%
$35.00$216,492-4.55%
2025-07-03SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
4,266
0.0037%
$27.77$118,473+15.73%
2025-01-06SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
54,215
0.0488%
$42.75$2.32M-29.98%
2024-07-30SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
18,026
0.0164%
$57.13$1.03M-40.73%
2024-05-01SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
281,425
0.2627%
$78.66$22.14M-31.97%
2023-04-17SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
12,500
0.0163%
$20.00$250,000-4.46%
2023-03-29SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
41,242
0.0529%
$16.00$659,872+11.3%
2023-03-28SaleViking Therapeutics, Inc.
VKTX
Chief Operating Officer
196,563
0.2437%
$15.00$2.95M+14.7%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.